<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7613873</journal-id>
<journal-id journal-id-type="pubmed-jr-id">4137</journal-id>
<journal-id journal-id-type="nlm-ta">Hum Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Genet.</journal-id>
<journal-title-group>
<journal-title>Human genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0340-6717</issn>
<issn pub-type="epub">1432-1203</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30656451</article-id>
<article-id pub-id-type="pmc">6425760</article-id>
<article-id pub-id-type="doi">10.1007/s00439-019-01971-4</article-id>
<article-id pub-id-type="manuscript">NIHMS1518997</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Integrative Genomic Analysis Predicts Novel Functional Enhancer-SNPs
for Bone Mineral Density</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Qiu</surname>
<given-names>Chuan</given-names>
</name>
<xref ref-type="author-notes" rid="FN1">ยง</xref>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shen</surname>
<given-names>Hui</given-names>
</name>
<xref ref-type="author-notes" rid="FN1">ยง</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fu</surname>
<given-names>Xiaoying</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Chao</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tian</surname>
<given-names>Qing</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Deng</surname>
<given-names>Hongwen</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1.</label> Center for Bioinformatics and Genomics, Department of
Global Biostatistics and Data Science, School of Public Health and Tropical
Medicine, Tulane University, New Orleans, 70112, USA</aff>
<aff id="A2"><label>2.</label> Department of Biostatistics and Epidemiology, University
of Oklahoma Health Sciences Center, Oklahoma City, 73104, USA</aff>
<aff id="A3"><label>3.</label> School of Basic Medical Science, Central South
University, Changsha, 410013, China</aff>
<author-notes>
<fn id="FN1">
<label>ยง</label>
<p id="P1">These authors contributed equally to this work</p>
</fn>
<corresp id="CR1"><label>*</label><bold>To whom correspondence should be addressed at:</bold> Hui Shen, Ph. D.,
Associate Professor, Department of Global Biostatistics and Data Science, School
of Public Health and Tropical Medicine, Tulane University, 1440 Canal Street,
Suite 1601, New Orleans, LA 70112, USA, Phone: 504-988-6987, Fax: 504-988-1706,
<email>hshen3@tulane.edu</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p id="P31">Compliance with ethical standards</p>
<p id="P32">Conflict of interest</p>
<p id="P33">The authors declare that they have no competing interests.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>17</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>17</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>2</month>
<year>2020</year>
</pub-date>
<volume>138</volume>
<issue>2</issue>
<fpage>167</fpage>
<lpage>185</lpage>
<!--elocation-id from pubmed: 10.1007/s00439-019-01971-4-->
<abstract id="ABS1">
<p id="P2">Osteoporosis is a skeletal disorder characterized by low bone mineral
density (BMD) and deterioration of bone microarchitecture. To identify novel
genetic loci underlying osteoporosis, an effective strategy is to focus on
scanning of variants with high potential functional impacts. Enhancers play a
crucial role in regulating cell type-specific transcription. Therefore, single
nucleotide polymorphisms (SNPs) located in enhancers (enhancer-SNPs) may
represent strong candidate functional variants. Here, we performed a targeted
analysis for potential functional enhancer-SNPs that may affect gene expression
and biological processes in bone-related cells, specifically, osteoblasts and
peripheral blood monocytes (PBMs), using five independent cohorts (n = 5,905)
and the Genetics Factors for Osteoporosis (GEFOS) summary statistics, followed
by comprehensive integrative genomic analyses of chromatin states,
transcription, and metabolites. We identified 15 novel enhancer-SNPs associated
with femoral neck and lumbar spine BMD, including 5 SNPs mapped to novel genes
(e.g., <italic>rs10840343</italic> and <italic>rs10770081</italic> in
<italic>IGF2</italic> gene) and 10 novel SNPs mapped to known BMD-associated
genes (e.g., <italic>rs2941742</italic> in <italic>ESR1</italic> gene<italic>,
rs10249092</italic> and <italic>rs4342522</italic> in <italic>SHFM1</italic>
gene). Interestingly, enhancer-SNPs <italic>rs10249092</italic> and
<italic>rs4342522</italic> in <italic>SHFM1</italic> were tightly linked but
annotated to different enhancers in PBMs and osteoblasts respectively,
suggesting even tightly linked SNPs may regulate the same target gene and
contribute to the phenotype variation in cell type-specific manners.
Importantly, 10 enhancer-SNPs may also regulate BMD variation by affecting the
serum metabolite levels. Our findings revealed novel susceptibility loci that
may regulate BMD variation and provided intriguing insights into the genetic
mechanisms of osteoporosis.</p>
</abstract>
<kwd-group>
<kwd>Osteoporosis</kwd>
<kwd>BMD</kwd>
<kwd>Meta-analysis</kwd>
<kwd>Enhancer-SNPs</kwd>
<kwd>Integrative Genomic Analysis</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>